FTCM
CERO

Fir Tree Capital Management’s CERo Therapeutics CERO Stock Holding History

Fir Tree Capital Management’s Portfolio CERO Stock Details CERO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-85
Closed -$1.75M – 303
2022
Q4 		$1.75M Sell
85
-166
-66% -$3.38M 0.09% 253
2022
Q3 		$5.06M Hold
251
– – 0.17% 185
2022
Q2 		$5.03M Buy
251
+126
+101% +$2.52M 0.16% 202
2022
Q1 		$2.5M Hold
125
– – 0.07% 341
2021
Q4 		$2.48M Buy
+125
New +$2.48M 0.07% 349

Other funds holding CERO

MC
Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
MTCM
Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 19.06% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
KL
KIM LLC Wichita, Kansas $976M AUM 0.91% 1-Year Est. Return
WRBC
W.R. Berkley Corp Greenwich, Connecticut $1.86B AUM 14.44% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Fir Tree Capital Management's CERO Position: Q1 2023 in Review

Fir Tree Capital Management sold out of CERo Therapeutics (CERO) in Q1 2023, closing a stake of 85 shares — an estimated $1.75M sold.

Fir Tree Capital Management first reported a position in CERO in Q4 2021 and held it in 5 quarters. The position peaked at $5.06M in Q3 2022. 15 funds tracked by Wall St. Rank hold CERO as of Q1 2023.

  • Fir Tree Capital Management reported no remaining CERo Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Fir Tree Capital Management sold 85 CERo Therapeutics shares in Q1 2023, an estimated $1.75M.
  • Fir Tree Capital Management first reported a position in CERo Therapeutics in Q4 2021 and held it in 5 quarters.
  • Fir Tree Capital Management's CERo Therapeutics position peaked at $5.06M in Q3 2022.
  • 15 funds tracked by Wall St. Rank held CERo Therapeutics as of Q1 2023.

Based on Fir Tree Capital Management's 13F filing for Q1 2023, filed 15 May 2023.